EW

EW Other Income/Expenses (Net)

-$412.00MTTM · USD

Period ending:

EW FY Other Income/Expenses (Net)USD
EW FY Other Income/Expenses (Net)1999-12-31: -$4.00M2000-12-31: -$354.00M2001-12-31: -$33.10M2002-12-31: $3.90M2003-12-31: -$45.60M2004-12-31: -$124.30M2005-12-31: -$58.90M2006-12-31: $8.80M2007-12-31: -$19.70M2008-12-31: -$44.60M2009-12-31: $71.40M2010-12-31: -$14.30M2011-12-31: -$45.50M2012-12-31: -$5.60M2013-12-31: $82.30M2014-12-31: $656.80M2015-12-31: $46.50M2016-12-31: -$77.60M2017-12-31: $24.80M2018-12-31: -$330.90M2019-12-31: -$31.40M2020-12-31: -$379.30M2021-12-31: $91.60M2022-12-31: $65.00M2023-12-31: -$54.90M2024-12-31: $169.40M2025-12-31: -$363.30M$656.80M-$379.30M
1999-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

EW other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 27 observations from Dec 31, 1999 to Dec 31, 2025.

Edwards Lifesciences Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
-363,300,000
169,400,000
-54,900,000
65,000,000
91,600,000
-379,300,000
-31,400,000
-330,900,000
24,800,000
-77,600,000
46,500,000
656,800,000
82,299,999
-5,600,000
-45,500,000
-14,300,000
71,400,000
-44,600,000
-19,700,000
8,800,000
-58,900,000
-124,300,000
-45,600,000
3,900,000
-33,100,000
-354,000,000
-4,000,000

Compare other income/expenses (net)

All EW financial metrics · EW stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.